Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study.

Khalil M, Langkammer C, Pichler A, Pinter D, Gattringer T, Bachmaier G, Ropele S, Fuchs S, Enzinger C, Fazekas F.

Neurology. 2015 Jun 16;84(24):2396-402. doi: 10.1212/WNL.0000000000001679. Epub 2015 May 15.

PMID:
25979698
2.

Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome.

Al-Radaideh AM, Wharton SJ, Lim SY, Tench CR, Morgan PS, Bowtell RW, Constantinescu CS, Gowland PA.

Mult Scler. 2013 Jun;19(7):896-903. doi: 10.1177/1352458512465135. Epub 2012 Nov 8.

PMID:
23139386
3.

Determinants of iron accumulation in deep grey matter of multiple sclerosis patients.

Ropele S, Kilsdonk ID, Wattjes MP, Langkammer C, de Graaf WL, Frederiksen JL, Larsson HB, Yiannakas M, Wheeler-Kingshott CA, Enzinger C, Khalil M, Rocca MA, Sprenger T, Amann M, Kappos L, Filippi M, Rovira A, Ciccarelli O, Barkhof F, Fazekas F.

Mult Scler. 2014 Nov;20(13):1692-8. doi: 10.1177/1352458514531085. Epub 2014 Apr 30.

PMID:
24787429
4.

[Reduced signal intensity of T2 weighted MR imaging of thalamus and putamen in multiple sclerosis in Japan].

Nishii T, Hirata A, Masaki T, Kaida K, Nakamura R, Motoyoshi K, Kamakura K.

Rinsho Shinkeigaku. 2000 Jul;40(7):677-82. Japanese.

PMID:
11186904
5.

Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study.

Khalil M, Langkammer C, Ropele S, Petrovic K, Wallner-Blazek M, Loitfelder M, Jehna M, Bachmaier G, Schmidt R, Enzinger C, Fuchs S, Fazekas F.

Neurology. 2011 Nov 1;77(18):1691-7. doi: 10.1212/WNL.0b013e318236ef0e. Epub 2011 Oct 5.

PMID:
21975210
6.

Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis.

Khalil M, Enzinger C, Langkammer C, Tscherner M, Wallner-Blazek M, Jehna M, Ropele S, Fuchs S, Fazekas F.

Mult Scler. 2009 Sep;15(9):1048-54. doi: 10.1177/1352458509106609. Epub 2009 Jun 25.

PMID:
19556316
7.

Iron-Insensitive Quantitative Assessment of Subcortical Gray Matter Demyelination in Multiple Sclerosis Using the Macromolecular Proton Fraction.

Yarnykh VL, Krutenkova EP, Aitmagambetova G, Repovic P, Mayadev A, Qian P, Jung Henson LK, Gangadharan B, Bowen JD.

AJNR Am J Neuroradiol. 2018 Apr;39(4):618-625. doi: 10.3174/ajnr.A5542. Epub 2018 Feb 8.

8.

Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.

Chu R, Hurwitz S, Tauhid S, Bakshi R.

BMC Neurol. 2017 Sep 5;17(1):172. doi: 10.1186/s12883-017-0949-4.

9.

Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using three-dimensional (3D)-enhanced T2*-weighted angiography (ESWAN).

Du S, Sah SK, Zeng C, Wang J, Liu Y, Xiong H, Li Y.

Eur J Radiol. 2015 Jul;84(7):1325-32. doi: 10.1016/j.ejrad.2015.04.013. Epub 2015 Apr 25.

PMID:
25959392
10.

Multiple sclerosis: improved identification of disease-relevant changes in gray and white matter by using susceptibility-based MR imaging.

Rudko DA, Solovey I, Gati JS, Kremenchutzky M, Menon RS.

Radiology. 2014 Sep;272(3):851-64. doi: 10.1148/radiol.14132475. Epub 2014 May 14.

PMID:
24828000
11.

Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study.

Zivadinov R, Heininen-Brown M, Schirda CV, Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E, Hagemeier J, Benedict RH, Weinstock-Guttman B, Dwyer MG.

Neuroimage. 2012 Jan 2;59(1):331-9. doi: 10.1016/j.neuroimage.2011.07.045. Epub 2011 Jul 27.

PMID:
21820063
12.

The role of iron in gray matter degeneration in Huntington's disease: a magnetic resonance imaging study.

Sánchez-Castañeda C, Squitieri F, Di Paola M, Dayan M, Petrollini M, Sabatini U.

Hum Brain Mapp. 2015 Jan;36(1):50-66. doi: 10.1002/hbm.22612. Epub 2014 Aug 21.

PMID:
25145324
13.

Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis.

Ceccarelli A, Rocca MA, Neema M, Martinelli V, Arora A, Tauhid S, Ghezzi A, Comi G, Bakshi R, Filippi M.

Mult Scler. 2010 Jan;16(1):39-44. doi: 10.1177/1352458509350310. Epub 2009 Nov 13.

PMID:
19965516
14.

Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study.

Zivadinov R, Schirda C, Dwyer MG, Haacke ME, Weinstock-Guttman B, Menegatti E, Heininen-Brown M, Magnano C, Malagoni AM, Wack DS, Hojnacki D, Kennedy C, Carl E, Bergsland N, Hussein S, Poloni G, Bartolomei I, Salvi F, Zamboni P.

Int Angiol. 2010 Apr;29(2):158-75.

PMID:
20351672
15.

Longitudinal MR imaging of iron in multiple sclerosis: an imaging marker of disease.

Walsh AJ, Blevins G, Lebel RM, Seres P, Emery DJ, Wilman AH.

Radiology. 2014 Jan;270(1):186-96. doi: 10.1148/radiol.13130474. Epub 2013 Oct 28.

PMID:
23925273
16.

Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis.

Neema M, Arora A, Healy BC, Guss ZD, Brass SD, Duan Y, Buckle GJ, Glanz BI, Stazzone L, Khoury SJ, Weiner HL, Guttmann CR, Bakshi R.

J Neuroimaging. 2009 Jan;19(1):3-8. doi: 10.1111/j.1552-6569.2008.00296.x.

17.

Relationship between iron accumulation and white matter injury in multiple sclerosis: a case-control study.

Raz E, Branson B, Jensen JH, Bester M, Babb JS, Herbert J, Grossman RI, Inglese M.

J Neurol. 2015 Feb;262(2):402-9. doi: 10.1007/s00415-014-7569-3. Epub 2014 Nov 22.

18.

Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging.

Ge Y, Jensen JH, Lu H, Helpern JA, Miles L, Inglese M, Babb JS, Herbert J, Grossman RI.

AJNR Am J Neuroradiol. 2007 Oct;28(9):1639-44. Epub 2007 Sep 24.

19.

Subcortical gray matter segmentation and voxel-based analysis using transverse relaxation and quantitative susceptibility mapping with application to multiple sclerosis.

Cobzas D, Sun H, Walsh AJ, Lebel RM, Blevins G, Wilman AH.

J Magn Reson Imaging. 2015 Dec;42(6):1601-10. doi: 10.1002/jmri.24951. Epub 2015 May 18.

PMID:
25980643
20.

Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: A two-year longitudinal study.

Uddin MN, Lebel RM, Seres P, Blevins G, Wilman AH.

Mult Scler. 2016 Aug;22(9):1133-43. doi: 10.1177/1352458515614091. Epub 2015 Oct 26.

PMID:
26503237

Supplemental Content

Support Center